Daily market recaps with key events, stock movements, and global influences Bhavneesh Sharma MBBS, MD, MBA (Finance) @bs2537 Capricorn’ $CAPR deramiocel (CAP-1002) is the only allogeneic cell therapy in FDA review for DMD, repeat-dosed and genotype-agnostic. Uniquely tackles cardiomyopathy—the #1 killer in DMD— with durable 3-year functional and cardiac benefits.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with AI-Designed
Contact AI-Designed, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack